PF4 and systemic sclerosis: Disposing of PBMCs from the SSc patients of the replication cohort, we could test the proliferative response of SSc T-helper cells to CXCL4 by bromodeoxyuridine (BrdU) incorporation, as previously done with other autoantigens [24,25].